Both GHRP-6 and GHRP-2 are growth hormone releasing peptides that work on the ghrelin receptor, yet they behave quite differently. Understanding these distinctions is important for research protocol selection.
GHRP-6:
Produces stronger GH release per dose. Creates significant hunger increase (it strongly activates ghrelin). Elevated cortisol and prolactin elevation occur. More widely available and generally cheaper. Better suited for research contexts where increased appetite is desired (bulking protocols).
GHRP-2:
Produces slightly less GH release than GHRP-6. Much less hunger stimulation occurs. Lower cortisol and prolactin impact. Generally considered "cleaner" with fewer side effects. Better suited for research where appetite changes are undesirable.
For most peptide research, GHRP-2 or Ipamorelin is the preferred choice. GHRP-6's hunger effects are intense — reported as "eating a full meal then being starving 30 minutes later" by researchers.
Both are typically paired with a GHRH (CJC-1295 or Mod GRF 1-29) for synergistic GH release. This combination creates stronger GH pulses than either compound alone.
